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Editorial Comment 
Stabilizing the Care of 
Unstable Angina* 
SIDNEY GOLDSTEIN,  MD, FACC 
Detroit, Michigan 
The role of the cardiologist in the therapeutic hierarchy of 
health care is being challenged by many of our colleagues from 
different medical disciplines, even in a domain that has been 
traditionally theirs: the treatment of unstable angina. This 
competition is occurring as a result of both economic and 
therapeutic pressures. The urgency to initiate cardiac are for 
patients with acute coronary syndromes is occurring in an 
environment of cost containment and benefit analysis. In 
another era, when cost had no relevancy and care had little 
urgency, we cardiologists thrived. But, alas, the world has 
changed. 
As the front line of care moves from the consultation room 
to the emergency department, the cardiologists must reassess 
their position in both the professional nd economic landscape 
of acute cardiac care. The emergency department and coro- 
nary care unit represent very important fields of play in which 
cardiologists have a rightful place and in which they can and 
must add to the quality of care rendered to the patient with 
acute ischemic syndromes. Yet, this arena is increasingly 
controlled by emergency physicians and internists emboldened 
in their ability to care for the patient with acute coronary 
syndrome as a result of research created and promulgated by 
the cardiology community. At the same time, the economic 
pressures of managed care are placing numerous barriers in 
the way of the cardiologist participating in patient care. The 
question of who is in charge and who is the leader of this team 
may yet be determined by nonmedical forces. At present, 
however, it is still dominated by professional decision makers. 
So the appropriate question is, Who can best care for the patient 
with ischemic syndromes such as unstable angina? The cardiolo- 
gist? The emergency physician? Or the general internist? 
Outcome measurements. The report by Schreiber et al. (1) 
in this issue of the Journal raises important issues with regard 
to one critical ischemic diagnostic ategory: the relative per- 
formance of the internist and cardiologist in the treatment of 
unstable angina. In comparing the effectiveness of the internist 
and cardiologist in the treatment of this syndrome, Schreiber et 
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al. have, by the nature of the clinical entity, included a very 
mixed population of both patients and physicians. What are the 
appropriate measures of quality of care and how can they be 
quantified? The authors measure performance by the number 
of diagnostic procedures ordered, the type of pharmacologic 
and interventional ction initiated and hospital mortality. They 
indicate that the patients treated by the cardiologist had a 
threefold increase in diagnostic procedures, largely angio- 
graphic, compared with patients treated by the internist. The 
authors focus on this difference and suggest that the internist- 
treated patients were ill served. This difference, however, is not 
surprising because the patients cared for by the cardiologist 
more often had preexisting coronary disease, whereas the 
internist saw many more patients with new onset and atypical 
chest pain. As a result, internists used angiography less fre- 
quently and ordered fewer diagnostic studies, including exer- 
cise testing before hospital discharge. However, it is also quite 
likely that many internist-treated patients discharged from the 
hospital with a diagnosis of unstable angina did not have 
coronary heart disease. Surely, every patient with atypical chest 
pain should not have an angiogram. Nevertheless, it appears 
that there was indeed an underutilization of noninvasive valua- 
tion of these patients by internists. The recently published clinical 
practice guidelines on unstable angina (2) advise xercise testing 
in low and intermediate risk patients within 72 h. It is, however 
imprecise to compare the use of diagnostic procedures in these 
very disparate patients cared for by different physicians. 
Schreiber et al. also examined the differences in medical 
therapy for these patients, calling on randomized clinical trials 
as the "gold" standard. They observed that heparin and aspirin 
were used more frequently by cardiologists, and beta- 
adrenergic blocking agents were used relatively infrequently by 
both physician groups. In sharp contrast, calcium channel 
blocking agents were used twice as frequently by cardiologists 
as internists, this in the face of the lack of any reported benefit 
of these agents. With that exception, cardiologists tended to 
use more clinically proven therapeutic strategies than inter- 
nists. In a recent study comparing eneralists and cardiologists 
with regard to treatment of acute myocardial infarction, Aya- 
nian et al. (3) made similar observations. They observed that 
cardiologists used thrombolytic agents, aspirin and beta- 
blockers more frequently and were less likely to use prophy- 
lactic lidocaine or diltiazem, particularly in the setting of 
pulmonary congestion, than generalists. Ayanian et al. sug- 
gested that this difference in drug utilization was due to an 
information lag experienced by the generalist in the rapidly 
changing field of acute cardiac therapeutics. Cardiologists 
often receive their information from a more focused source, 
like journals, rather than generalists who depended on infor- 
mation gained from textbooks, which have an inherent lag. 
Schreiber et al. (1) also noted more frequent use of angioplasty 
in patients with unstable angina treated by cardiologists and 
suggest that this, too, is evidence for suboptimal care by 
internists. It is possible to make an argument for a more 
aggressive diagnostic and interventional procedure in these 
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patients. Nevertheless, in an even higher isk population with 
unstable angina nd non-Q wave myocardial infarction, when 
an invasive therapeutic strategy was compared with conserva- 
tive strategy, no difference in mortality and morbidity was 
observed (4). 
Schreiber et al. (1) make a case for superiority of care 
rendered by the cardiologist, basing their argument on the 
increased application of technology (i.e., angiography and 
angioplasty) in the face of no measurable improvement in
morbidity and mortality in the cardiologist-treated patients. 
These observations support aprevious tudy (5) that indicated 
that the specialist, particularly the cardiologist, ends to use 
more expensive diagnostic techniques without a measurable 
benefit in morbidity and mortality. Nevertheless, there were 
trends observed in mortality that favored the cardiologist. This 
occurred in the face of a higher observed risk factor in the 
cardiologist-treated patients, including increased frequency of 
previous myocardial infarction, diabetes, previous angioplasty 
and coronary bypass urgery. A more sophisticated statistical 
analysis, taking into consideration the baseline risk factors, 
might have provided support for better care by the cardiologist. 
Because of the lack of comparison data between cardiolo- 
gists and internists in the United States, investigators have 
turned to other countries that represent prototypes ofdifferent 
health care systems. A recent comparison (6) was made 
between the Canadian and U.S. patients enrolled in a multi- 
center clinical trial. The U.S. patients had greater access to 
specialty care and had more frequent interventional proce- 
dures compared with the patients enrolled in Canada. Al- 
though many other factors could have affected the observed 
outcome, the symptomatic status was significantly better and 
the risk-adjusted survival higher in the U.S. patients than in 
Canadian patients. 
Collaborative practice and the work force. Health econo- 
mists have advocated the wider use of family practitioners and 
internists rather than specialists as the entry point to health 
care. This has been unabashedly motivated by economic 
imperatives. Money aside, there is a great deal to be said for 
the generalist as an appropriate entry point for many patients, 
but probably not for those with acute coronary syndromes. The 
fact remains that over two thirds of patients eeking care for 
ischemic heart disease and angina see a general practitioner o  
an internist first (7). The role of the cardiologist in a managed 
care system will change as these systems require generalists for 
screening of patients. However, the number of practicing 
cardiologists will remain the same even if efforts to downsize 
training programs are successful. The number of trainees 
already in the pipeline and the youth of the current cardiology 
practitioners will determine this. The role of the cardiologist in 
the future logistic of acute care will have to change. More of us 
will be positioned in the coronary, care unit and perhaps the 
emergency department, if for no other reason than to find a 
place of employment. As a counterbalance, some cardiologists 
are now advocating angiography as the essential diagnostic tool 
for acute ischemic syndromes and angioplasty as the optimal 
therapy for acute myocardial infarction. Whether or not this 
approach is valid for the diagnosis of unstable angina, as Schre- 
iber et al. suggest, remains for larger scale clinical trials to reveal. 
At best, however, itwill be applicable to a relatively few medical 
facilities with angiographic laboratories ready and waiting. 
As Schreiber et al. indicate, the cardiologist must play an 
active role in emergency medical care systems and in the 
emergency departments of their community hospitals, where 
the treatment decisions are being made. This is where cardi- 
ologists can most appropriately have an impact on the therapy 
of unstable angina nd where both internists and cardiologists 
can build a cohesive pattern of care for patients with unstable 
angina nd acute ischemic heart disease. 
Future research. The study by Schreiber et al. (1) is a first 
and very important step in responding to the questions of the 
value of specialty care in cardiology. The authors are to be 
complimented ontheir courage to proceed in these uncharted 
waters. Unfortunately, we have very little comparable data at 
hand. It is imperative that the cardiology community look 
carefully not only at quality outcomes, but at the cost of our 
diagnostic and therapeutic procedures. In health care systems 
that integrate the total care of the patient, not just those who 
unfortunately experience an acute event such as unstable 
angina, primary and secondary prevention become major ways 
to achieve significant savings in health care costs and save lives. 
The cardiologist can energize efforts in this direction as we 
continue to examine clinical strategies of care using random- 
ized clinical trials. No medical specialty has used this investi- 
gative methodology as widely and in as grand a scale as 
cardiology. We have advanced our knowledge of the natural 
history and the treatment of ischemic heart disease immensely 
in the last half-century. A number of very provocative ques- 
tions now face cardiologists as we defend our specialty. Now is 
the time to apply the lessons that we have learned from clinical 
trials to the measurement of the outcome of care that we 
provide our patients. Our ability to convince the public and 
colleagues of the value and quality of cardiovascular care will 
depend on data supporting the positive outcome of our special 
knowledge and skills. 
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